tiprankstipranks
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market

Ensysce Biosciences (ENSC) Income Statement

Compare
255 Followers

Ensysce Biosciences Income Statement

Last quarter (Q4 2024), Ensysce Biosciences's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Ensysce Biosciences's net income was $-3.56M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 2.23M$ 2.52M$ 3.53M$ 3.93M
Gross Profit
$ 0.00$ -5.36M$ -17.31M$ 3.53M$ 2.56M
Operating Expenses
$ 11.94T$ 5.36M$ 24.22M$ 19.87M$ 1.61M
Depreciation and Amortization
$ 0.00$ -3.00$ 151.00$ 151.00$ 201.00
EBITDA
$ -6.73T$ -10.72M$ -24.22M$ -19.87M$ -1.61M
Operating Income
$ -6.73T$ -10.72M$ -24.22M$ -19.87M$ -1.61M
Other Income/Expenses
$ -1.26T$ 91.91K$ 14.41K$ -9.28M$ 1.45M
Pretax Income
$ -7.99T$ -10.63M$ -24.21M$ -29.15M$ -160.88K
Net Income
$ -7.99T$ -10.61M$ -24.96M$ -29.15M$ -938.73K
Per Share Metrics
Basic EPS
$ -11.45K$ -4.69$ -138.73$ -346.90$ -14.29
Diluted EPS
$ -11.45K$ -4.69$ -138.73$ -346.90$ -13.65
Weighted Average Shares Outstanding
697.69M 2.26M 179.93K 84.02K 65.70K
Weighted Average Shares Outstanding (Diluted)
697.69M 2.26M 179.93K 84.02K 68.78K
Currency in USD

Ensysce Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis